784966008: Product containing precisely epinephrine (as epinephrine bitartrate) 500 microgram/1 milliliter and guanethidine 2.5 milligram/1 milliliter conventional release eye solution (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product\...

\Medicinal product categorised by disposition\Adrenergic receptor agonist-containing product\Beta adrenergic receptor agonist-containing product\Alpha-adrenergic and beta-adrenergic agonist-containing product\Adrenaline-containing product\Adrenaline-containing product in ocular dose form\Adrenaline- and guanethidine-containing product in ocular dose form\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Medicinal product categorised by disposition\Adrenergic receptor agonist-containing product\Beta adrenergic receptor agonist-containing product\Alpha-adrenergic and beta-adrenergic agonist-containing product\Adrenaline-containing product\Adrenaline- and guanethidine-containing product\Adrenaline and guanethidine only product\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Medicinal product categorised by disposition\Adrenergic receptor agonist-containing product\Beta adrenergic receptor agonist-containing product\Alpha-adrenergic and beta-adrenergic agonist-containing product\Adrenaline-containing product\Adrenaline- and guanethidine-containing product\Adrenaline- and guanethidine-containing product in ocular dose form\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Medicinal product categorised by disposition\Adrenergic receptor agonist-containing product\Alpha adrenergic receptor agonist-containing product\Alpha-adrenergic and beta-adrenergic agonist-containing product\Adrenaline-containing product\Adrenaline-containing product in ocular dose form\Adrenaline- and guanethidine-containing product in ocular dose form\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Medicinal product categorised by disposition\Adrenergic receptor agonist-containing product\Alpha adrenergic receptor agonist-containing product\Alpha-adrenergic and beta-adrenergic agonist-containing product\Adrenaline-containing product\Adrenaline- and guanethidine-containing product\Adrenaline and guanethidine only product\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Medicinal product categorised by disposition\Adrenergic receptor agonist-containing product\Alpha adrenergic receptor agonist-containing product\Alpha-adrenergic and beta-adrenergic agonist-containing product\Adrenaline-containing product\Adrenaline- and guanethidine-containing product\Adrenaline- and guanethidine-containing product in ocular dose form\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Medicinal product categorised by disposition\Adrenergic neurone blocker-containing product\Guanethidine-containing product\Guanethidine-containing product in ocular dose form\Adrenaline- and guanethidine-containing product in ocular dose form\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Medicinal product categorised by disposition\Adrenergic neurone blocker-containing product\Guanethidine-containing product\Adrenaline- and guanethidine-containing product\Adrenaline and guanethidine only product\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Medicinal product categorised by disposition\Adrenergic neurone blocker-containing product\Guanethidine-containing product\Adrenaline- and guanethidine-containing product\Adrenaline- and guanethidine-containing product in ocular dose form\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Medicinal product categorised by disposition\Hormone-containing product\Adrenal hormone-containing product\Adrenal medulla hormone-containing product\Adrenaline-containing product\Adrenaline-containing product in ocular dose form\Adrenaline- and guanethidine-containing product in ocular dose form\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Medicinal product categorised by disposition\Hormone-containing product\Adrenal hormone-containing product\Adrenal medulla hormone-containing product\Adrenaline-containing product\Adrenaline- and guanethidine-containing product\Adrenaline and guanethidine only product\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Medicinal product categorised by disposition\Hormone-containing product\Adrenal hormone-containing product\Adrenal medulla hormone-containing product\Adrenaline-containing product\Adrenaline- and guanethidine-containing product\Adrenaline- and guanethidine-containing product in ocular dose form\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution

\Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Catecholamine-containing product\Adrenaline-containing product\...

\Adrenaline-containing product in ocular dose form\Adrenaline- and guanethidine-containing product in ocular dose form\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution

\Adrenaline- and guanethidine-containing product\Adrenaline and guanethidine only product\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Adrenaline- and guanethidine-containing product\Adrenaline- and guanethidine-containing product in ocular dose form\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution

\Medicinal product categorised by therapeutic role\Antiglaucoma agent\Adrenaline-containing product in ocular dose form\Adrenaline- and guanethidine-containing product in ocular dose form\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution

\Product manufactured as ocular dose form\Adrenaline-containing product in ocular dose form\Adrenaline- and guanethidine-containing product in ocular dose form\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Product manufactured as ocular dose form\Guanethidine-containing product in ocular dose form\Adrenaline- and guanethidine-containing product in ocular dose form\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution

\Autonomic agent\Adrenergic neurone blocker-containing product\Guanethidine-containing product\Guanethidine-containing product in ocular dose form\Adrenaline- and guanethidine-containing product in ocular dose form\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Autonomic agent\Adrenergic neurone blocker-containing product\Guanethidine-containing product\Adrenaline- and guanethidine-containing product\Adrenaline and guanethidine only product\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Autonomic agent\Adrenergic neurone blocker-containing product\Guanethidine-containing product\Adrenaline- and guanethidine-containing product\Adrenaline- and guanethidine-containing product in ocular dose form\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Autonomic agent\Sympathomimetic-containing product\Adrenergic receptor agonist-containing product\Beta adrenergic receptor agonist-containing product\Alpha-adrenergic and beta-adrenergic agonist-containing product\Adrenaline-containing product\Adrenaline-containing product in ocular dose form\Adrenaline- and guanethidine-containing product in ocular dose form\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Autonomic agent\Sympathomimetic-containing product\Adrenergic receptor agonist-containing product\Beta adrenergic receptor agonist-containing product\Alpha-adrenergic and beta-adrenergic agonist-containing product\Adrenaline-containing product\Adrenaline- and guanethidine-containing product\Adrenaline and guanethidine only product\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Autonomic agent\Sympathomimetic-containing product\Adrenergic receptor agonist-containing product\Beta adrenergic receptor agonist-containing product\Alpha-adrenergic and beta-adrenergic agonist-containing product\Adrenaline-containing product\Adrenaline- and guanethidine-containing product\Adrenaline- and guanethidine-containing product in ocular dose form\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Autonomic agent\Sympathomimetic-containing product\Adrenergic receptor agonist-containing product\Alpha adrenergic receptor agonist-containing product\Alpha-adrenergic and beta-adrenergic agonist-containing product\Adrenaline-containing product\Adrenaline-containing product in ocular dose form\Adrenaline- and guanethidine-containing product in ocular dose form\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Autonomic agent\Sympathomimetic-containing product\Adrenergic receptor agonist-containing product\Alpha adrenergic receptor agonist-containing product\Alpha-adrenergic and beta-adrenergic agonist-containing product\Adrenaline-containing product\Adrenaline- and guanethidine-containing product\Adrenaline and guanethidine only product\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Autonomic agent\Sympathomimetic-containing product\Adrenergic receptor agonist-containing product\Alpha adrenergic receptor agonist-containing product\Alpha-adrenergic and beta-adrenergic agonist-containing product\Adrenaline-containing product\Adrenaline- and guanethidine-containing product\Adrenaline- and guanethidine-containing product in ocular dose form\Adrenaline and guanethidine only product in ocular dose form\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution

Status: current, Defined. Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3765863011 Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution en Synonym Active Initial character case insensitive SNOMED CT core

3765864017 Product containing precisely epinephrine (as epinephrine bitartrate) 500 microgram/1 milliliter and guanethidine 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) en Fully specified name Active Case insensitive SNOMED CT core

3765865016 Epinephrine (as epinephrine bitartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution en Synonym Active Initial character case insensitive SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	Has concentration strength denominator unit	mL	true	Inferred relationship	Some	1
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	Plays role	Antiglaucoma therapeutic role	true	Inferred relationship	Some
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	Has manufactured dose form	Eye solution	true	Inferred relationship	Some
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	Count of base of active ingredient	2	false	Inferred relationship	Some
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	Has concentration strength denominator unit	mL	true	Inferred relationship	Some	2
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	Has concentration strength denominator value	1	false	Inferred relationship	Some	2
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	Is a	Adrenaline and guanethidine only product in ocular dose form	true	Inferred relationship	Some
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	Has concentration strength denominator value	1	false	Inferred relationship	Some	1
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	Has concentration strength numerator value	2.5	false	Inferred relationship	Some	2
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	Has concentration strength numerator unit	mg	true	Inferred relationship	Some	2
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	Has precise active ingredient	Adrenaline acid tartrate	true	Inferred relationship	Some	1
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	Has BoSS	Adrenaline	true	Inferred relationship	Some	1
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	Has concentration strength numerator value	500	false	Inferred relationship	Some	1
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	Has precise active ingredient	Guanethidine	true	Inferred relationship	Some	2
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	Has concentration strength numerator unit	mcg	true	Inferred relationship	Some	1
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	Has BoSS	Guanethidine	true	Inferred relationship	Some	2

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3765863011	Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	en	Synonym	Active	Initial character case insensitive	SNOMED CT core
3765864017	Product containing precisely epinephrine (as epinephrine bitartrate) 500 microgram/1 milliliter and guanethidine 2.5 milligram/1 milliliter conventional release eye solution (clinical drug)	en	Fully specified name	Active	Case insensitive	SNOMED CT core
3765865016	Epinephrine (as epinephrine bitartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	en	Synonym	Active	Initial character case insensitive	SNOMED CT core